RSS Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises

Currently reading:
 RSS Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
9,903
Likes
1,923
Credits
33,507©
Cash
0$
Shares of Unity Biotechnology, Inc. (UBX) are experiencing a 9% increase in pre-market trading following the announcement of Federico Grossi's appointment as Chief Medical Officer. Federico Grossi expressed his enthusiasm about advancing UBX1325 and expanding the pipeline to offer new, distinctive treatment options for individuals with progressive retinal diseases. With two decades of experience and extensive expertise in ophthalmology, Grossi is well-equipped for this role. He previously held the position of Chief Medical Officer at Apellis Pharmaceuticals.

On Friday, UBX saw a 12.28% increase, closing at $1.28 on the Nasdaq. In pre-market trading, the company's value has risen an additional 8.59%, reaching $1.39.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips

Similar threads

Top Bottom